Announcements Trials
Browse Landscape

Phase

Phase 2 11Phase 1 5Phase 1/2 4Phase NA 1Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 372Neoplasms 263Prostatic Neoplasms 188Lung Neoplasms 137Colorectal Neoplasms 128Head and Neck Neoplasms 76Colonic Neoplasms 67Pancreatic Neoplasms 63Carcinoma, Non-Small-Cell Lung 63Carcinoma, Hepatocellular 61Uterine Cervical Neoplasms 57Multiple Myeloma 54Precursor Cell Lymphoblastic Leukemia-Lymphoma 53Neoplasm Metastasis 51Leukemia, Myeloid, Acute 50Brain Neoplasms 48Liver Neoplasms 44Rectal Neoplasms 42Melanoma 42Motor Activity 41Lymphoma, Non-Hodgkin 41Lymphoma 39Leukemia 38Pain 37Ovarian Neoplasms 36Hodgkin Disease 36Fatigue 34Depression 34Barrett Esophagus 34Lymphoma, Follicular 33

Interventions

Valganciclovir 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Has results × Sarcoma, Kaposi × Clear all
NCT00096538 2015-11-25

Valganciclovir in Treating Patients With Classic Non-HIV-Associated Kaposi's Sarcoma

Memorial Sloan Kettering Cancer Center

Phase NA Completed
6 enrolled 6 charts
Sarcoma

Sarcoma, Sarcoma, Kaposi

Data powered by HemOnc (CC BY 4.0) Colophon âš¡